Literature DB >> 12653536

Active learning with support vector machines in the drug discovery process.

Manfred K Warmuth1, Jun Liao, Gunnar Rätsch, Michael Mathieson, Santosh Putta, Christian Lemmen.   

Abstract

We investigate the following data mining problem from computer-aided drug design: From a large collection of compounds, find those that bind to a target molecule in as few iterations of biochemical testing as possible. In each iteration a comparatively small batch of compounds is screened for binding activity toward this target. We employed the so-called "active learning paradigm" from Machine Learning for selecting the successive batches. Our main selection strategy is based on the maximum margin hyperplane-generated by "Support Vector Machines". This hyperplane separates the current set of active from the inactive compounds and has the largest possible distance from any labeled compound. We perform a thorough comparative study of various other selection strategies on data sets provided by DuPont Pharmaceuticals and show that the strategies based on the maximum margin hyperplane clearly outperform the simpler ones.

Mesh:

Year:  2003        PMID: 12653536     DOI: 10.1021/ci025620t

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  46 in total

Review 1.  Big-Data Science in Porous Materials: Materials Genomics and Machine Learning.

Authors:  Kevin Maik Jablonka; Daniele Ongari; Seyed Mohamad Moosavi; Berend Smit
Journal:  Chem Rev       Date:  2020-06-10       Impact factor: 60.622

2.  A support vector machine approach to classify human cytochrome P450 3A4 inhibitors.

Authors:  Jan M Kriegl; Thomas Arnhold; Bernd Beck; Thomas Fox
Journal:  J Comput Aided Mol Des       Date:  2005-03       Impact factor: 3.686

Review 3.  Molecular similarity and diversity in chemoinformatics: from theory to applications.

Authors:  Ana G Maldonado; J P Doucet; Michel Petitjean; Bo-Tao Fan
Journal:  Mol Divers       Date:  2006-02       Impact factor: 2.943

4.  Functional census of mutation sequence spaces: the example of p53 cancer rescue mutants.

Authors:  Samuel A Danziger; S Joshua Swamidass; Jue Zeng; Lawrence R Dearth; Qiang Lu; Jonathan H Chen; Jianlin Cheng; Vinh P Hoang; Hiroto Saigo; Ray Luo; Pierre Baldi; Rainer K Brachmann; Richard H Lathrop
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2006 Apr-Jun       Impact factor: 3.710

5.  Computer-aided drug design: the next 20 years.

Authors:  John H Van Drie
Journal:  J Comput Aided Mol Des       Date:  2007-11-08       Impact factor: 3.686

Review 6.  Using genetic findings in autism for the development of new pharmaceutical compounds.

Authors:  Jacob A S Vorstman; Will Spooren; Antonio M Persico; David A Collier; Stefan Aigner; Ravi Jagasia; Jeffrey C Glennon; Jan K Buitelaar
Journal:  Psychopharmacology (Berl)       Date:  2013-11-30       Impact factor: 4.530

7.  An improved scoring function for suboptimal polar ligand complexes.

Authors:  Giovanni Cincilla; David Vidal; Miquel Pons
Journal:  J Comput Aided Mol Des       Date:  2008-10-09       Impact factor: 3.686

8.  Diagnosis of several diseases by using combined kernels with Support Vector Machine.

Authors:  Turgay Ibrikci; Deniz Ustun; Irem Ersoz Kaya
Journal:  J Med Syst       Date:  2011-01-11       Impact factor: 4.460

9.  A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery.

Authors:  Ignacio Aliagas; Alberto Gobbi; Timothy Heffron; Man-Ling Lee; Daniel F Ortwine; Mark Zak; S Cyrus Khojasteh
Journal:  J Comput Aided Mol Des       Date:  2015-02-24       Impact factor: 3.686

10.  KiDoQ: using docking based energy scores to develop ligand based model for predicting antibacterials.

Authors:  Aarti Garg; Rupinder Tewari; Gajendra P S Raghava
Journal:  BMC Bioinformatics       Date:  2010-03-11       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.